Abstract

Abstract Purpose: In the context of in vitro fertilization treatment ovarian hyperstimulation syndrome can lead to a serious illness. Its pathogenesis is not fully understood, but is associated with several cytokines, enzymes and growth factors. VEGF is considered among others to be a significant factor. The aim of the present study was to investigate whether there are correlations between VEGF serum concentrations and clinical and biochemical parameters of ovarian hyperstimulation syndrome. Thus, VEGF could be used as a clinical parameter of ovarian hyperstimulation syndrome. Methods: Three patient groups were formed in which VEGF measurements were performed. In the first group, patients with ovarian hyperstimulation syndrome after stimulation treatment and hospitalization were examined. In the second group, patients with stimulation for in vitro fertilization but without OHSS were considered and in the third group, patients without stimulation treatment were recorded. The groups were comparatively statistically evaluated. Results: There was a clear association between the VEGF scores and duration of hospitalization in the diseased patients. The VEGF determinations did not differentiate between stimulated patients with and without ovarian hyperstimulation syndrome. However, there was a significant difference between stimulated and unstimulated patients. Conclusion: The determination of VEGF seems to be of limited use as a clinically useful parameter for the assessment and prognosis of ovarian hyperstimulation syndrome. Methodological weakness of the retrospective study design should be a reason for caution in interpreting the results.

Highlights

  • Ovarian hyperstimulation syndrome is a potentially life-threatening condition, which can occur as part of an in vitro fertilization treatment [1].Over the past 10 years, severe ovarian hyperstimulation syndromes have been reported less frequently

  • The determination of Vascular Endothelial Growth Factor (VEGF) seems to be of limited use as a clinically useful parameter for the assessment and prognosis of ovarian hyperstimulation syndrome

  • For the body mass index, no meaningful correlation could be found in the VEGF measurements, but a slight positive correlation between maximum weight gain during hospital stay and maximum VEGF level could be observed, which correlates with known data

Read more

Summary

Introduction

Ovarian hyperstimulation syndrome is a potentially life-threatening condition, which can occur as part of an in vitro fertilization treatment [1]. Over the past 10 years, severe ovarian hyperstimulation syndromes have been reported less frequently. The German IVF Register (D.I.R) for example recorded 0.32% overstimulation syndromes grade III (WHO classification) in 2008. In 2017, the share was only 0.2%. This can be attributed for example to the increasing use of the antagonist

Objectives
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call